You are here: Industry Insights > variant

News List

Neandertal gene variants both increase and decrease the risk for severe COVID-19 worldpharmanews
February 20, 2021
Last year, researchers at Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany showed that a major genetic risk factor for severe COVID-19 is inherited from Neandertals.
EU launches vaccine incubator to tackle Covid-19 variant threat pharmaceutical-technology
February 20, 2021
The European Union (EU) has set up an incubator to help prepare member states against emerging variants of SARS-CoV-2, the virus which causes Covid-19. Covid-19 variants have been emerging across the world, including B117 in the UK and B1351 in ...
South African variant may weaken vaccine protection: Pfizer expresspharma
February 20, 2021
The study found the vaccine was still able to neutralise the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said.
Vaccine trials essential to evaluate effectiveness against new COVID-19 variants: GlobalData expresspharma
February 10, 2021
The largest proportion of the ongoing vaccine trials are now in Phase II (38.6 per cent) and Phase III (36.3 per cent), after Phase I studies dominated the earlier period of the pandemic.
UK says COVID-19 booster and annual vaccinations very probable expresspharma
February 08, 2021
Among coronavirus variants currently most concerning for scientists and public health experts are the so-called British, South African and Brazilian variants.
CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants contractpharma
February 07, 2021
Aims to mitigate the effects of the pandemic and help prepare against future SARS-CoV-2 outbreaks by working on multiple variant vaccines.
IHME extends COVID-19 forecasts to June 1, predicting over 3.5 million deaths globally prnasia
February 05, 2021
The latest COVID-19 forecasts from the Institute for Health Metrics and Evaluation at the University of Washington School of Medicine predict more than 3.5 million deaths globally by June 1.
In vitro studies demonstrate Pfizer and BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with key mutations present in U.K. and South African variants worldpharmanews
February 03, 2021
Pfizer Inc. and BioNTech SE announced results from in vitro neutralization studies of sera from individuals vaccinated with the Pfizer-BioNTech COVID-19 vaccine.
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants prnasia
February 01, 2021
South Korea's biotechnology firm Seegene (KQ096530) said Monday it developed the world's first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.
Omixon, SeqOnce Announce Extension to AzureSeq-200 Assay to Detect SARS-CoV-2 N501Y Variant americanpharmaceuticalreview
February 01, 2021
Omixon and SeqOnce Biosciences announce the launch of a new extension to the AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant.

Previous page 1 2 3 4 5 6 7 Next page